Status:
COMPLETED
Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)
Lead Sponsor:
Medtronic Vascular
Conditions:
Uncontrolled Hypertension
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
An international, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation in patients with uncontrolled hypertension.
Eligibility Criteria
Inclusion
- systolic blood pressure \>=160mmHg (\>=150 mmHg for type 2 diabetics);
- on 3 or more antihypertensive medications
- \>= 18 and =\< 85 years of age.
Exclusion
- renal artery abnormalities
- eGFR \< 45mL/min
- MI, angina, CVA within 6 months
- Type 1 diabetes
- ICD or pacemaker, or any other metallic implant not compatible with MRI
- others
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00888433
Start Date
June 1 2009
End Date
May 1 2015
Last Update
May 20 2015
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Australia
2
Vienna General Hospital
Vienna, Austria
3
Cliniques Universitaires Saint Luc
Brussels, Belgium
4
Hopital Européen Georges Pompidou
Paris, France